Upadacitinib for Refractory Alopecia Areata Unresponsive to Prior Systemic Therapies: A Retrospective Study

Published: 21 November 2024| Version 1 | DOI: 10.17632/zs5fkwwg6d.1
Contributor:
Wang Qin

Description

Supplemental table detailing baseline SALT scores, changes in SALT scores, and serum IgE levels for each patient with refractory alopecia areata following treatment with Upadacitinib.

Files

Institutions

Huashan Hospital Fudan University

Categories

Alopecia Areata

Funding

National Natural Science Foundation of China

82373507, 82173442 and 82473552

Licence